Literature DB >> 33075718

Athletes with an ACL reconstruction show a different neuromuscular response to environmental challenges compared to uninjured athletes.

Annemie Smeets1, Sabine Verschueren2, Filip Staes3, Hilde Vandenneucker4, Steven Claes5, Jos Vanrenterghem6.   

Abstract

BACKGROUND: Evidence suggests that neuromuscular alterations in patients with an anterior cruciate ligament reconstruction (ACLR) are rooted in neurocognitive and proprioceptive deficits. The aim of this study was to assess neuromuscular control of athletes with ACLR under increased cognitive and environmental challenges. RESEARCH QUESTION: Do athletes with ACLR show a different neuromuscular response to cognitive and environmental challenges relative to controls?
METHODS: Cross-sectional study. Twenty athletes who had an ACLR (age: 23.7 ± 4.3 years, 14 males, time post-surgery: 258.6 ± 54 days) and twenty uninjured controls (age: 21.4 ± 1.5 years, 14 males) performed a stepping down-task in four environmental conditions: no additional challenges, while performing a cognitive dual-task, while undergoing an unpredictable support surface perturbation, and with the cognitive dual-task and unpredictable perturbation combined. Muscle activations of the vastus medialis (VM), vastus lateralis, hamstrings medialis (HM), hamstrings lateralis (HL), gastrocnemius medialis, gastrocnemius lateralis (GL) and gluteus medius were recorded with surface EMG. A three-way ANOVA with main effects for group, dual-task and perturbation was used to compare muscle activations.
RESULTS: Athletes with ACLR show larger HM (ES = 0.45) and HL activation (ES = 1.32) and lower VM activation (ES = 0.72), compared to controls. Athletes with ACLR show a significantly smaller increase in VM (ES = 0.69), VL (ES = 0.53) and GL activation (ES = 0.52) between perturbed and unperturbed tasks compared to controls. Furthermore, under cognitive loading a significantly larger decrease in HM activation (ES = 0.40) and (medial) co-contraction (ES = 0.75) was found in athletes with ACLR compared to controls. SIGNIFICANCE: Athletes with ACLR show an altered neuromuscular response which might represent an arthrogenic muscle response. They show less additional adaptation to perturbed tasks compared to controls, potentially as result of altered proprioceptive input. Furthermore a larger influence of increased cognitive loading on the neuromuscular control was found in athletes with ACLR, indicating that also neurocognitive limitations may contribute to altered neuromuscular control.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ACL reconstruction; Cognitive loads; Environmental constraints; Neuromuscular control; Perturbation

Mesh:

Year:  2020        PMID: 33075718     DOI: 10.1016/j.gaitpost.2020.09.032

Source DB:  PubMed          Journal:  Gait Posture        ISSN: 0966-6362            Impact factor:   2.840


  4 in total

1.  Hamstrings Neuromuscular Function After Anterior Cruciate Ligament Reconstruction: A Systematic Review and Meta-Analysis.

Authors:  David A Sherman; Neal R Glaviano; Grant E Norte
Journal:  Sports Med       Date:  2021-02-20       Impact factor: 11.136

2.  Neuromuscular Control During Stair Descent and Artificial Tibial Translation After Acute ACL Rupture.

Authors:  Angela Blasimann; Aglaja Busch; Philipp Henle; Sven Bruhn; Dirk Vissers; Heiner Baur
Journal:  Orthop J Sports Med       Date:  2022-10-13

3.  Finishing stationary cycling too early after anterior cruciate ligament reconstruction is likely to lead to higher failure.

Authors:  Balázs Sonkodi; Endre Varga; László Hangody; Gyula Poór; István Berkes
Journal:  BMC Sports Sci Med Rehabil       Date:  2021-11-25

4.  Electromyographic Assessment of Anterior Cruciate Ligament Injury Risk in Male Tennis Players: Which Role for Visual Input? A Proof-of-Concept Study.

Authors:  Alessandro de Sire; Nicola Marotta; Andrea Demeco; Lucrezia Moggio; Pasquale Paola; Marcello Marotta; Teresa Iona; Marco Invernizzi; Massimiliano Leigheb; Antonio Ammendolia
Journal:  Diagnostics (Basel)       Date:  2021-05-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.